To access the full text documents, please follow this link: http://hdl.handle.net/2445/134518
dc.contributor.author | Douglass, Caitlin H. |
---|---|
dc.contributor.author | Pedrana, Alisa |
dc.contributor.author | Lazarus, Jeffrey V. |
dc.contributor.author | Hoen, Ellen F. M. ‘t |
dc.contributor.author | Hammad, Radi |
dc.contributor.author | Baptista-Leite, Ricardo |
dc.contributor.author | Hill, Andrew |
dc.contributor.author | Hellard, Margaret |
dc.date | 2019-06-04T11:57:51Z |
dc.date | 2019-06-04T11:57:51Z |
dc.date | 2018-10-09 |
dc.date | 2019-05-27T08:58:28Z |
dc.identifier.citation | 1741-7015 |
dc.identifier.uri | http://hdl.handle.net/2445/134518 |
dc.format | 9 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | BioMed Central |
dc.relation | Reproducció del document publicat a: http://dx.doi.org/ 10.1186/s12916-018-1162-z |
dc.relation | BMC Medicine, 2018, vol. 16, num. 175 |
dc.relation | http://dx.doi.org/ 10.1186/s12916-018-1162-z |
dc.rights | cc by (c) Douglass et al., 2018 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by/3.0/es/ |
dc.subject | Hepatitis C |
dc.subject | Medicaments antivírics |
dc.subject | Antiviral agents |
dc.title | Pathways to ensure universal and affordable access to hepatitis C treatment |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |